India enjoys an important position in the global pharmaceuticals sector with a 20% share of generic medicines in supplies by volume. Indian pharmaceutical sector industry supplies over 50 per cent of global demand for various vaccines, 40% of generic demand in the US and 25% of all medicine in UK.
India is the source of 60,000 generic brands across 60 therapeutic categories and manufactures more than 500 different Active Pharmaceutical Ingredients (APIs). The export of generic drugs is one of India's core strengths. The export of Pharmaceuticals stood at $16.3 bn in 2015-16. Presently over 80% of the antiretroviral drugs used globally to combat AIDS are supplied by Indian pharmaceutical firms.
100% Foreign Direct Investment (FDI) in pharmaceuticals in India is allowed under the automatic route for green-field pharma.
100% Fdi In Drugs And Pharmaceuticals In India is allowed in brownfield pharma; wherein 74% FDI in the Pharmaceuticals Sector is allowed under the automatic route and thereafter through government approval route.
Largest vaccine producer in the world
Bio-Pharma is the largest sector contributing to 62% of the total revenue
4th largest medical device market in Asia
The pharmaceutical sector was valued at USD $33 bn in 2017. The country’s pharmaceutical industry is expected to expand at a CAGR of 22.4% over 2015–20 to reach USD $55 bn
India’s pharmaceutical exports stood at USD $17.27 bn in FY18 and have reached USD $15.52 bn in FY19 (up to January 2019)
The Pharmaceutical industry in India accounts for about 2.4% of the global Pharmaceutical industry in value terms
Indian companies received 304 Abbreviated New Drug Application (ANDA) approvals from the US Food and Drug Administration (USFDA) in 2017. The country accounts for around 30% (by volume) and about 10% (value) in the USD $70-80 bn US generics market
Generic drugs with 70% market share form the largest segment of the Pharmaceutical industry in India. Over-the-counter (OTC) medicines constitute around 21% of the market while patented drugs have a 9% share
India is currently among the top 20 global Medical device markets and the 4th largest medical device market in Asia
Will changes in FDI norms lead to more employment??
Policy Watch - Review of FDI Policy - FDI India
India Received Highest-Ever FDI Of Over $64 Billion In 2018-19
Cabinet decisions: 100?I in contract manufacturing under automatic route
The Big Picture - Wooing FDI - FDI India